{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T23:54:51Z","timestamp":1788134091847,"version":"build-2803163510"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                    <jats:title>Summary:<\/jats:title>\n                    <jats:p>Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a malignancy associated with textured breast implants. BIA-ALCL is typically restricted to the periprosthetic capsule, presenting as a unilateral recurrent seroma years after placement of a textured breast implant. Current estimates suggest an incidence of one in 3300 for patients with Allergan Biocell textured implants. As of February 6, 2019, U.S. Medical Device Reporting associated with BIA-ALCL showed 457 unique cases of BIA-ALCL, with 24 \u201cunverified and potentially inaccurate\u201d cases associated with a nontextured implant. As of February of 2019, there were 688 reported cases to date worldwide. To date, there are no published case reports of BIA-ALCL associated exclusively with smooth implants or with smooth implants after textured expanders, and there has been no reported smooth-only case in any registry, database, or journal worldwide. The authors present a case of BIA-ALCL associated with smooth round implants and textured tissue expanders. A 56-year-old woman was treated for left stage IIA invasive ductal carcinoma with bilateral mastectomies and immediate reconstruction with bilateral subpectoral textured tissue expanders. She underwent exchange to Mentor smooth-round implants, and completed adjuvant chemotherapy. Magnetic resonance imaging and examination 4.5 years after implant placement showed no abnormal findings. The patient had left breast trauma 5 years following implant placement while taking adalimumab, and developed an open wound requiring explantation. A recurrent seroma developed, and tested positive for BIA-ALCL on cytology. Surgical pathologic examination after total capsulectomy demonstrated stage IA BIA-ALCL. To the authors\u2019 knowledge, this is the first case report of BIA-ALCL in a patient with textured expanders followed by prolonged exposure to smooth round implants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/prs.0000000000008155","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T14:04:22Z","timestamp":1623852262000},"page":"299-303","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["An Unusual Case of BIA-ALCL Associated with Prolonged\/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab"],"prefix":"10.1097","volume":"148","author":[{"given":"Arya A.","family":"Akhavan","sequence":"first","affiliation":[{"name":"From the Division of Plastic Surgery and the Division of Surgical Oncology, University of North Carolina Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Wirtz","sequence":"additional","affiliation":[{"name":"From the Division of Plastic Surgery and the Division of Surgical Oncology, University of North Carolina Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Ollila","sequence":"additional","affiliation":[{"name":"From the Division of Plastic Surgery and the Division of Surgical Oncology, University of North Carolina Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Bhatt","sequence":"additional","affiliation":[{"name":"From the Division of Plastic Surgery and the Division of Surgical Oncology, University of North Carolina Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,15]]},"reference":[{"key":"R1-20250501","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11899-018-0478-2","article-title":"Breast implant-associated anaplastic large cell lymphoma.","volume":"13","author":"Rastogi","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"R2-20250501","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1245\/s10434-017-6014-0","article-title":"Implications of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) for breast cancer reconstruction: An update for surgical oncologists.","volume":"24","author":"O\u2019Neill","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R3-20250501","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/PRS.0000000000005500","article-title":"The epidemiology of breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand confirms the highest risk for grade 4 surface breast implants.","volume":"143","author":"Magnusson","year":"2019","journal-title":"Plast Reconstr Surg"},{"key":"R5-20250501","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/00006534-199708000-00065","article-title":"Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant.","volume":"100","author":"Keech","year":"1997","journal-title":"Plast Reconstr Surg"},{"key":"R6-20250501","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/asj\/sjw259","article-title":"NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma.","volume":"37","author":"Clemens","year":"2017","journal-title":"Aesthet Surg J"},{"key":"R7-20250501","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.2147\/OTT.S141053","article-title":"Brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma: An evidence-based review.","volume":"11","author":"Donato","year":"2018","journal-title":"Onco Targets Ther"},{"key":"R8-20250501","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/asj\/sjw023","article-title":"Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma.","volume":"36","author":"Kadin","year":"2016","journal-title":"Aesthet Surg J"},{"key":"R9-20250501","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-016-3745-8","article-title":"MSCs and inflammation: New insights into the potential association between ALCL and breast implants.","volume":"156","author":"Orciani","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"R10-20250501","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.humpath.2018.04.007","article-title":"IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: Implications for pathogenesis.","volume":"78","author":"Kadin","year":"2018","journal-title":"Hum Pathol"},{"key":"R11-20250501","first-page":"1631","article-title":"Breast implant-associated ALK-negative anaplastic large cell lymphoma: A case report and discussion of possible pathogenesis.","volume":"6","author":"George","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"R12-20250501","first-page":"2414278","article-title":"Breast implant-associated anaplastic large cell lymphoma: Case report and review of the literature.","volume":"2018","author":"Berlin","year":"2018","journal-title":"Case Rep Hematol"},{"key":"R13-20250501","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-3034-3","article-title":"Breast implant-associated anaplastic large cell lymphoma: Sensitivity, specificity, and findings of imaging studies in 44 patients.","volume":"147","author":"Adrada","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R14-20250501","first-page":"1","article-title":"Methotrexate-associated primary cutaneous CD30-positive cutaneous T-cell lymphoproliferative disorder: A case illustration and a brief review.","volume":"6","author":"Claudino","year":"2016","journal-title":"Am J Blood Res"},{"key":"R15-20250501","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/MEG.0b013e32834bb90a","article-title":"Hepatosplenic T-cell lymphoma in patients receiving TNF-\u03b1 inhibitor therapy: Expanding the groups at risk.","volume":"23","author":"Parakkal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R16-20250501","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2014\/687592","article-title":"Anaplastic large cell lymphoma of the colon in a patient with colonic Crohn disease treated with infliximab and methotrexate.","volume":"28","author":"Shukla","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R17-20250501","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jdcr.2014.12.006","article-title":"Primary cutaneous anaplastic large cell lymphoma in a patient receiving adalimumab.","volume":"1","author":"Hruska","year":"2015","journal-title":"JAAD Case Rep"},{"key":"R18-20250501","doi-asserted-by":"crossref","first-page":"811e","DOI":"10.1097\/PRS.0000000000002622","article-title":"Anaplastic large cell lymphoma: Emerging consent and management patterns among American and international board-certified plastic surgeons.","volume":"138","author":"Pittman","year":"2016","journal-title":"Plast Reconstr Surg"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000008155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T20:11:38Z","timestamp":1746130298000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PRS.0000000000008155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,15]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000008155","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,15]]}}}